Sanofi-aventis, one of the world's largest diversified healthcare companies, reports earnings for the first-quarter of 2009. CEO Chris Viehbacher comments on earnings, strategy and R&D pipeline review.
Use these links to watch the video interview in the format of your choice:
Windows Media Player:
http://www.eurobusinessmedia.com/interviewWmp.php?id_article=449
Flash Player:
http://www.eurobusinessmedia.com/interviewFlash.php?id_article=449
Use this link to read the interview transcript:
http://www.eurobusinessmedia.com/transcript.php?id_article=449
Topics covered in the interview include:
- Q1 earnings & FY guidance
- Progress in new strategy
-
R&D pipeline review
- Multaq hopes & outlook
-
Transformation program
- Acquisition strategy
- Emerging
markets trends
- US healthcare reform
- Lovenox generic threat
About Sanofi-aventis:
Sanofi-aventis, a leading global diversified healthcare company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).
Company website: http://en.sanofi-aventis.com/home.asp
Sanofi-aventis
Investor Relations : IR@sanofi-aventis.com
or
Media
Relations : MR@sanofi-aventis.com
